May 23, 2024By Matt Fates, Partner, and Jeff Knox, Associate Summary The world has grand ambitions to build much of tomorrow’s materials…
January 11, 2024By Matt Fates, Partner and Jeff Knox, Associate Summary The last two decades have seen tremendous expansion of biological…
October 17, 2023Meet Luca Giani, CEO of Ilios Therapeutics, a biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases.
August 8, 2023Summary In drug development, new molecular entities get all the press. That’s largely justified – new molecules mean new medicines…
June 14, 2023Even before Generative AI caught fire, computationally aided drug discovery was an area of intense interest for researchers. It should…
July 7, 2022As skilled and advanced as the $2T pharma industry is in many regards, there are still key areas where it…
